{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:08:21Z","timestamp":1793826501318,"version":"4.6.1"},"reference-count":127,"publisher":"Centers for Disease Control MMWR Office","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Recomm. Rep."],"DOI":"10.15585\/mmwr.rr7201a1","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T07:21:25Z","timestamp":1678346485000},"page":"1-25","source":"Crossref","is-referenced-by-count":262,"title":["Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations \u2014 United States, 2023"],"prefix":"10.15585","volume":"72","author":[{"given":"Erin E.","family":"Conners","sequence":"first","affiliation":[{"name":"Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi","family":"Panagiotakopoulos","sequence":"additional","affiliation":[{"name":"Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan G.","family":"Hofmeister","sequence":"additional","affiliation":[{"name":"Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip R.","family":"Spradling","sequence":"additional","affiliation":[{"name":"Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesl M.","family":"Hagan","sequence":"additional","affiliation":[{"name":"Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M.","family":"Harris","sequence":"additional","affiliation":[{"name":"Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica S.","family":"Rogers-Brown","sequence":"additional","affiliation":[{"name":"Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Wester","sequence":"additional","affiliation":[{"name":"Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noele P.","family":"Nelson","sequence":"additional","affiliation":[{"name":"Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Contributors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Rapposelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Sandul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Coffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su H.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2023,3,10]]},"reference":[{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R1","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1093\/cid\/ciy598","article-title":"Mortality among patients with chronic hepatitis B infection: the Chronic Hepatitis Cohort Study (CHeCS).","volume":"68","author":"Bixler","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R2","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.jhep.2015.01.020","article-title":"Causes of death in people with chronic HBV infection: a population-based cohort study.","volume":"62","author":"Montuclard","year":"2015","journal-title":"J Hepatol"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R3","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0140-6736(81)90585-7","article-title":"Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan.","volume":"2","author":"Beasley","year":"1981","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R4","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1001\/archinte.1990.00390170087019","article-title":"Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska Native carriers.","volume":"150","author":"McMahon","year":"1990","journal-title":"Arch Intern Med"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R5","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1002\/hep.31991","article-title":"Prevalence of hepatitis B virus (HBV) infection, vaccine-induced immunity, and susceptibility among at-risk populations: U.S. households, 2013\u20132018.","volume":"74","author":"Roberts","year":"2021","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R6","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/hep.31782","article-title":"An updated assessment of chronic hepatitis B prevalence among foreign-born persons living in the United States.","volume":"74","author":"Wong","year":"2021","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R7","unstructured":"American Community Survey 1-Year Public Use Microdata Sample (PUMS) 2018. Variables: place of birth and decade of entry. Washington, DC: US Department of Labor, Census Bureau; 2019. https:\/\/www.census.gov\/programs-surveys\/acs\/microdata\/access.2018.html"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/infdis\/151.4.599","article-title":"Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state.","volume":"151","author":"McMahon","year":"1985","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss7003a1","article-title":"Surveillance of vaccination coverage among adult populations\u2014United States, 2018.","volume":"70","author":"Lu","year":"2021","journal-title":"MMWR Surveill Summ"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B.","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R11","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R12","unstructured":"U.S. Department of Health and Human Services. Viral hepatitis national strategic plan for the United States: a roadmap to elimination (2021\u20132025). Washington, DC: US Department of Health and Human Services; 2020. https:\/\/www.hhs.gov\/sites\/default\/files\/Viral-Hepatitis-National-Strategic-Plan-2021-2025.pdf"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R13","unstructured":"World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022\u20132030. Geneva, Switzerland: World Health Organization; 2022. https:\/\/cdn.who.int\/media\/docs\/default-source\/hq-hiv-hepatitis-and-stis-library\/full-final-who-ghss-hiv-vh-sti_1-june2022.pdf?sfvrsn=7c074b36_1"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R14","first-page":"1","article-title":"Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.","volume":"57","author":"Weinbaum","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices.","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.15585\/mmwr.mm6715a5","article-title":"Recommendations of the Advisory Committee on Immunization Practices for use of a hepatitis B vaccine with a novel adjuvant.","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/infdis\/jiv748","article-title":"Antibody levels and protection after hepatitis B vaccine: results of a 30-year follow-up study and response to a booster dose.","volume":"214","author":"Bruce","year":"2016","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/cid\/cir270","article-title":"Hepatitis B and the need for a booster dose.","volume":"53","author":"Leuridan","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R19","doi-asserted-by":"publisher","first-page":"e1500","DOI":"10.1542\/peds.2013-2940","article-title":"Duration of protection after infant hepatitis B vaccination series.","volume":"133","author":"Middleman","year":"2014","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R20","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1002\/hep.32474","article-title":"Protection and antibody levels 35 years after primary series with hepatitis B vaccine and response to a booster dose.","volume":"76","author":"Bruce","year":"2022","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R21","first-page":"347","article-title":"Uptake and elimination of hepatitis B immunoglobulins after intramuscular application in man.","volume":"54","author":"Scheiermann","year":"1983","journal-title":"Dev Biol Stand"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R22","doi-asserted-by":"publisher","first-page":"482","DOI":"10.2105\/AJPH.2013.301601","article-title":"Estimating acute viral hepatitis infections from nationally reported cases.","volume":"104","author":"Klevens","year":"2014","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R23","unstructured":"CDC. Viral hepatitis surveillance\u2014United States, 2019. Atlanta, GA: US Department of Health and Human Services, CDC; 2021. https:\/\/www.cdc.gov\/hepatitis\/statistics\/2019surveillance\/index.htm"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R24","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/cid\/ciz841","article-title":"Trends in hepatitis B infection and immunity among women of childbearing age in the United States.","volume":"71","author":"Kushner","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.15585\/mmwr.mm6503a2","article-title":"Increases in acute hepatitis B virus infections\u2014Kentucky, Tennessee, and West Virginia, 2006\u20132013.","volume":"65","author":"Harris","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R26","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.14309\/ajg.0000000000000651","article-title":"Prevalence of chronic hepatitis B virus infection in the United States.","volume":"115","author":"Lim","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R27","doi-asserted-by":"publisher","first-page":"e20201823","DOI":"10.1542\/peds.2020-1823","article-title":"National Perinatal Hepatitis B Prevention Program: 2009\u20132017.","volume":"147","author":"Koneru","year":"2021","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.su7101a1","article-title":"Standards required for the development of CDC evidence-based guidelines.","volume":"71","author":"Carande-Kulis","year":"2022","journal-title":"MMWR Suppl"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jclinepi.2019.03.008","article-title":"Improving the content validity of the mixed methods appraisal tool: a\u00a0modified e-Delphi study.","volume":"111","author":"Hong","year":"2019","journal-title":"J Clin Epidemiol"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1017\/S0266462313000160","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.","volume":"29","author":"Husereau","year":"2013","journal-title":"Int J Technol Assess Health Care"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.15585\/mmwr.mm6803a2","article-title":"Characteristics of deceased solid organ donors and screening results for hepatitis B, C, and human immunodeficiency viruses\u2014United States, 2010\u20132017.","volume":"68","author":"Abara","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.diagmicrobio.2015.12.005","article-title":"Are current screening protocols for chronic hepatitis B virus infection adequate?","volume":"85","author":"Mortensen","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R33","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/hep.28109","article-title":"Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households: National Health and Nutrition Examination Survey (NHANES), 1988\u20132012.","volume":"63","author":"Roberts","year":"2016","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R34","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/TA.0b013e31822178bd","article-title":"HIV and hepatitis in an urban penetrating trauma population: unrecognized and untreated.","volume":"71","author":"Seamon","year":"2011","journal-title":"J Trauma"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R35","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1007\/s10903-009-9239-6","article-title":"Hepatitis B sero-prevalence and risk behaviors among immigrant men in a population-based household survey in low-income neighborhoods of northern California.","volume":"12","author":"Levy","year":"2010","journal-title":"J Immigr Minor Health"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R36","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1001\/jamaoncol.2018.6437","article-title":"Prevalence of hepatitis B virus, hepatitis C virus, and HIV infection among patients with newly diagnosed cancer from academic and community oncology practices.","volume":"5","author":"Ramsey","year":"2019","journal-title":"JAMA Oncol"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R37","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1177\/1078155219889116","article-title":"Universal hepatitis B screening and management in patients with cancer who received immunosuppressive chemotherapy.","volume":"26","author":"Thompson","year":"2020","journal-title":"J Oncol Pharm Pract"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R38","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.cgh.2019.07.056","article-title":"Prevalence of hepatitis B virus exposure in the Veterans Health Administration and association with military-related risk factors.","volume":"18","author":"Beste","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R39","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1001\/jama.2020.19750","article-title":"Screening for hepatitis B virus infection in nonpregnant adolescents and adults: updated evidence report and systematic review for the U.S. Preventive Services Task Force.","volume":"324","author":"Chou","year":"2020","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R40","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jhep.2012.11.044","article-title":"Hepatitis B screening: who to target? A French sexually transmitted infection clinic experience.","volume":"58","author":"Spenatto","year":"2013","journal-title":"J Hepatol"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R41","doi-asserted-by":"publisher","first-page":"e92266","DOI":"10.1371\/journal.pone.0092266","article-title":"Current state of and needs for hepatitis B screening: results of a large screening study in a low-prevalent, metropolitan region.","volume":"9","author":"Bottero","year":"2014","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R42","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.jhep.2015.01.011","article-title":"Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios.","volume":"62","author":"Wolffram","year":"2015","journal-title":"J Hepatol"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R43","doi-asserted-by":"publisher","first-page":"349","DOI":"10.7326\/0003-4819-159-5-201309030-00672","article-title":"Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement.","volume":"159","author":"Moyer","year":"2013","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R44","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1200\/JCO.2017.75.6387","article-title":"Models to predict hepatitis B virus infection among patients with cancer undergoing systemic anticancer therapy: a prospective cohort study.","volume":"36","author":"Hwang","year":"2018","journal-title":"J Clin Oncol"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R45","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/jpids\/pix062","article-title":"Prenatal screening for and prevalence of hepatitis B surface antigen in pregnant women and prevention of transmission to infants born to infected mothers\u2014Guam, 2014.","volume":"7","author":"Abara","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R46","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/ajg.2013.50","article-title":"Birth cohort screening for chronic hepatitis during colonoscopy appointments.","volume":"108","author":"Sears","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","article-title":"CDC recommendations for hepatitis C screening among adults\u2014United States, 2020.","volume":"69","author":"Schillie","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R48","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s10900-010-9339-1","article-title":"San Francisco hep B free: a grassroots community coalition to prevent hepatitis B and liver cancer.","volume":"36","author":"Bailey","year":"2011","journal-title":"J Community Health"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R49","first-page":"383","article-title":"Stopping a silent killer in the underserved Asian and Pacific Islander community: a chronic hepatitis B and liver cancer prevention clinic by medical students.","volume":"10","author":"Lin","year":"2009","journal-title":"Asian Pac J Cancer Prev"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R50","doi-asserted-by":"publisher","first-page":"e043672","DOI":"10.1136\/bmjopen-2020-043672","article-title":"Retrospective observational study of temporal trends and outcomes of hepatitis B screening in patients receiving rituximab.","volume":"10","author":"Haider","year":"2020","journal-title":"BMJ Open"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R51","doi-asserted-by":"publisher","first-page":"331","DOI":"10.37765\/ajmc.2020.44069","article-title":"The hepatitis B care cascade using administrative claims data, 2016.","volume":"26","author":"Harris","year":"2020","journal-title":"Am J Manag Care"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R52","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/cid\/ciw516","article-title":"Infrequent clinical assessment of chronic hepatitis B patients in United States general healthcare settings.","volume":"63","author":"Spradling","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R53","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s41124-018-0034-7","article-title":"Racial\/ethnic- and county-specific prevalence of chronic hepatitis B and its burden in California.","volume":"3","author":"Toy","year":"2018","journal-title":"Hepatol Med Policy"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R54","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s10620-014-3283-3","article-title":"Low treatment rates in patients meeting guideline criteria in diverse practice settings.","volume":"59","author":"Kim","year":"2014","journal-title":"Dig Dis Sci"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R55","doi-asserted-by":"publisher","first-page":"541","DOI":"10.15585\/mmwr.mm6719a2","article-title":"Community-based services to improve testing and linkage to care among non-US\u2013born persons with chronic hepatitis B virus infection\u2014three US programs, October 2014\u2013September 2017.","volume":"67","author":"Harris","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R56","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/cid\/ciab405","article-title":"Cost-effectiveness of one-time universal screening for chronic hepatitis B infection in adults in the United States.","volume":"74","author":"Toy","year":"2022","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R57","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/cid\/ciz001","article-title":"Prevalence of hepatitis B and hepatitis D virus infections in the United States, 2011\u20132016.","volume":"69","author":"Patel","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R58","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/OLQ.0000000000001632","article-title":"Cost-effectiveness of hepatitis B testing and vaccination of adults seeking care for sexually transmitted infections.","volume":"49","author":"Hutton","year":"2022","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R59","doi-asserted-by":"publisher","first-page":"477","DOI":"10.15585\/mmwr.mm7113a1","article-title":"Universal hepatitis B vaccination in adults aged 19\u201359 years: updated recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2022.","volume":"71","author":"Weng","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R60","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jceh.2020.08.001","article-title":"Higher levels of fibrosis in a cohort of veterans with chronic viral hepatitis are associated with extrahepatic cancers.","volume":"11","author":"Abutaleb","year":"2021","journal-title":"J Clin Exp Hepatol"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R61","first-page":"5","article-title":"Viral hepatitis B, active component, U.S. Armed Forces, 2000\u20132010.","volume":"18","author":"Armed Forces Health Surveillance Center (AFHSC)","year":"2011","journal-title":"MSMR"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R62","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/hep.29135","article-title":"Evaluation of hepatitis B reactivation among 62,920 veterans treated with oral hepatitis C antivirals.","volume":"66","author":"Belperio","year":"2017","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R63","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/hep.23461","article-title":"Hepatitis B virus infection among American patients with chronic hepatitis C virus infection: prevalence, racial\/ethnic differences, and viral interactions.","volume":"51","author":"Bini","year":"2010","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R64","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ijid.2020.01.025","article-title":"Hepatitis C virologic response in hepatitis B and C coinfected persons treated with directly acting antiviral agents: Results from ERCHIVES.","volume":"92","author":"Butt","year":"2020","journal-title":"Int J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R65","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.vaccine.2019.03.012","article-title":"Hepatitis B testing, care linkage, and vaccination coverage within a registry of hepatitis C infected patients.","volume":"37","author":"Harris","year":"2019","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R66","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1353\/hpu.2018.0094","article-title":"Increased health and social vulnerability among hepatitis C infected individuals co-infected with hepatitis B.","volume":"29","author":"Hom","year":"2018","journal-title":"J Health Care Poor Underserved"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R67","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/hep.26400","article-title":"Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus\u2013infected patients.","volume":"58","author":"Tyson","year":"2013","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R68","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1002\/hep.27337","article-title":"Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus\u2013infected patients.","volume":"60","author":"Kruse","year":"2014","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R69","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1053\/j.gastro.2017.12.002","article-title":"Hepatitis B virus infection and hepatitis C virus treatment in a large cohort of hepatitis C\u2013infected patients in the United States.","volume":"154","author":"Moorman","year":"2018","journal-title":"Gastroenterology"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R70","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1007\/s10900-018-0530-0","article-title":"Examining hepatitis A and B vaccination, and HBV reactivation monitoring during direct-acting antiviral therapy for hepatitis C.","volume":"43","author":"Davison","year":"2018","journal-title":"J Community Health"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R71","unstructured":"Food and Drug Administration. FDA drug safety communication: FDA warns about the risk of hepatitis B reactivating in some patients treated with direct-acting antivirals for hepatitis C. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2016. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-warns-about-risk-hepatitis-b-reactivating-some-patients-treated"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R72","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S2468-1253(18)30002-5","article-title":"Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis.","volume":"3","author":"M\u00fccke","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R73","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/jvh.12784","article-title":"Rare clinically significant hepatic events and hepatitis B reactivation occur more frequently following rather than during direct-acting antiviral therapy for chronic hepatitis C: data from a national US cohort.","volume":"25","author":"Serper","year":"2018","journal-title":"J Viral Hepat"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R74","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1097\/MCG.0000000000000986","article-title":"Risk of hepatitis B virus reactivation among patients treated with Ledipasvir-Sofosbuvir for hepatitis C virus infection.","volume":"52","author":"Yanny","year":"2018","journal-title":"J Clin Gastroenterol"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R75","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/1751-2980.12615","article-title":"Late development of hepatocellular carcinoma after viral clearance in patients with chronic hepatitis C: a need for continual surveillance.","volume":"19","author":"Tong","year":"2018","journal-title":"J Dig Dis"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R76","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/hep.24257","article-title":"Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C.","volume":"54","author":"Lok","year":"2011","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R77","doi-asserted-by":"publisher","first-page":"9328","DOI":"10.3748\/wjg.v19.i48.9328","article-title":"Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C.","volume":"19","author":"Reddy","year":"2013","journal-title":"World J Gastroenterol"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R78","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.2105\/AJPH.94.7.1218","article-title":"Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons.","volume":"94","author":"Macalino","year":"2004","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R79","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/jurban\/jth085","article-title":"Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities.","volume":"81","author":"Solomon","year":"2004","journal-title":"J Urban Health"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R80","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1097\/OLQ.0b013e31820bc86c","article-title":"Sexually transmitted infections and hepatitis in men with a history of incarceration.","volume":"38","author":"Sosman","year":"2011","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R81","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.2105\/AJPH.2004.047753","article-title":"Ongoing transmission of hepatitis B virus infection among inmates at a state correctional facility.","volume":"95","author":"Khan","year":"2005","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R82","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11524-008-9305-8","article-title":"Prevalence of infection with hepatitis B and C viruses and co-infection with HIV in three jails: a case for viral hepatitis prevention in jails in the United States.","volume":"86","author":"Hennessey","year":"2009","journal-title":"J Urban Health"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R83","first-page":"529","article-title":"Hepatitis B outbreak in a state correctional facility, 2000.","volume":"50","author":"CDC","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R84","doi-asserted-by":"publisher","first-page":"82S","DOI":"10.1177\/0033354920928491","article-title":"Opt-out testing pilot for sexually transmitted infections among immigrant detainees at 2 Immigration and Customs Enforcement Health Service Corps\u2013staffed detention facilities, 2018.","volume":"135","author":"Lederman","year":"2020","journal-title":"Public Health Rep"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R85","first-page":"678","article-title":"Transmission of hepatitis B virus in correctional facilities\u2014Georgia, January 1999\u2013June 2002.","volume":"53","author":"CDC","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R86","first-page":"209A","article-title":"Behavioral factors associated with HIV, HBV, HCV, and HTLV infections in U.S. blood donors.","volume":"90","author":"Custer","year":"2014","journal-title":"Transfusion"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R87","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1080\/14659890500420095","article-title":"Incarceration among young injectors in San Francisco: associations with risk for hepatitis C virus infection.","volume":"11","author":"Kittikraisak","year":"2006","journal-title":"J Subst Use"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R88","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1071\/SH20185","article-title":"Hepatitis B prevalence association with sexually transmitted infections: a systematic review and meta-analysis.","volume":"18","author":"Marseille","year":"2021","journal-title":"Sex Health"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R89","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/OLQ.0000000000001359","article-title":"Incidence and prevalence of sexually transmitted hepatitis B, United States, 2013\u20132018.","volume":"48","author":"Roberts","year":"2021","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R90","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1093\/jpids\/piu064","article-title":"Prevention of perinatal hepatitis B virus transmission.","volume":"3","author":"Nelson","year":"2014","journal-title":"J Pediatric Infect Dis Soc"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R91","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S0140-6736(83)90624-4","article-title":"Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine.","volume":"2","author":"Beasley","year":"1983","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R92","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1136\/bmj.38719.435833.7C","article-title":"Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis.","volume":"332","author":"Lee","year":"2006","journal-title":"BMJ"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R93","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R94","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/infdis\/jiab224","article-title":"Trends in prevalence and characteristics of resolved and current hepatitis B among US-born persons: National Health and Nutrition Examination Survey, 2001\u20132018.","volume":"224","author":"Ly","year":"2021","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R95","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1468-1293.2012.01036.x","article-title":"Determinants of incident chronic kidney disease and progression in a cohort of HIV-infected persons with unrestricted access to health care.","volume":"14","author":"Ganesan","year":"2013","journal-title":"HIV Med"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R96","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/QAI.0000000000000142","article-title":"HIV outcomes in hepatitis B virus coinfected individuals on HAART.","volume":"66","author":"Chun","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R97","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/infdis\/jir720","article-title":"Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters.","volume":"205","author":"Chun","year":"2012","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R98","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/j.1365-2893.2009.01249.x","article-title":"Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996\u20132007.","volume":"17","author":"Spradling","year":"2010","journal-title":"J Viral Hepat"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R99","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s10461-013-0670-2","article-title":"Hepatitis B virus (HBV) infection, immunity and susceptibility among men who have sex with men (MSM), Los Angeles County, USA.","volume":"18","author":"Pitasi","year":"2014","journal-title":"AIDS Behav"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R100","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2105\/AJPH.2006.101915","article-title":"The Young Men\u2019s Survey phase II: hepatitis B immunization and infection among young men who have sex with men.","volume":"98","author":"Weinbaum","year":"2008","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R101","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1046\/j.1523-1755.2003.00017.x","article-title":"Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS.","volume":"63","author":"Burdick","year":"2003","journal-title":"Kidney Int"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R102","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/ki.1977.78","article-title":"Host responses to hepatitis B infection in patients in a chronic hemodialysis unit.","volume":"12","author":"London","year":"1977","journal-title":"Kidney Int"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R103","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1001\/archinte.1979.03630390036015","article-title":"Duration of hepatitis B surface antigenemia (HBs Ag) in hemodialysis patients.","volume":"139","author":"Ribot","year":"1979","journal-title":"Arch Intern Med"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R104","first-page":"1","article-title":"Recommendations for preventing transmission of infections among chronic hemodialysis patients.","volume":"50","author":"Alter","year":"2001","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R105","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s11901-020-00557-3","article-title":"Hepatitis B virus elimination in the U.S.: time to dismantle barriers and implement solutions.","volume":"20","author":"Wang","year":"2021","journal-title":"Curr Hepatol Rep"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R106","unstructured":"CDC. Screening for viral hepatitis during the domestic medical examination of newly arrived refugees. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https:\/\/www.cdc.gov\/immigrantrefugeehealth\/guidelines\/domestic\/hepatitis-screening-guidelines.html"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R107","unstructured":"Title 21, Food and Drugs. 21 CFR \u00a7610.40 (2020). https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?FR=610.40"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R108","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/cld.883","article-title":"Reactivation of hepatitis B virus: a review of clinical guidelines.","volume":"15","author":"Myint","year":"2020","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R109","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1200\/JCO.20.01757","article-title":"Hepatitis B virus screening and management for patients with cancer prior to therapy: ASCO provisional clinical opinion update.","volume":"38","author":"Hwang","year":"2020","journal-title":"J Clin Oncol"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R110","first-page":"1","article-title":"CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management.","volume":"62","author":"Schillie","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R111","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s11136-020-02416-6","article-title":"Mental and physical health status among chronic hepatitis B patients.","volume":"29","author":"Daida","year":"2020","journal-title":"Qual Life Res"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R112","unstructured":"Tang A, Thornton K, Primary Care Workgroup HBV. Hepatitis B management: guidance for the primary care provider. Seattle, WA: University of Washington, National Hepatitis Training Center; 2020. https:\/\/www.hepatitisb.uw.edu\/page\/primary-care-workgroup\/guidance"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R113","doi-asserted-by":"publisher","first-page":"13S","DOI":"10.1177\/0033354920921252","article-title":"Protecting the rights of health care students living with hepatitis B under the Americans with Disabilities Act.","volume":"135","author":"Moraras","year":"2020","journal-title":"Public Health Rep"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R114","first-page":"1","article-title":"Updated CDC recommendations for the management of hepatitis B virus\u2013infected health-care providers and students.","volume":"61","author":"Holmberg","year":"2012","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R115","unstructured":"Samuels J, Galanter S, Rodriguez L. Joint agency letter to health-related graduate schools regarding hepatitis B discrimination. Washington, DC: US Departments of Justice, Health and Human Services, and Education; 2013. https:\/\/www.justice.gov\/iso\/opa\/resources\/732013612162552847322.pdf"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R116","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1053\/j.gastro.2017.02.009","article-title":"Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies, and future directions.","volume":"152","author":"Loomba","year":"2017","journal-title":"Gastroenterology"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R117","unstructured":"Food and Drug Administration. FDA drug safety communication: boxed warning and new recommendations to decrease risk of hepatitis B reactivation with the immune-suppressing and anti-cancer drugs Arzerra (ofatumumab) and Rituxan (rituximab). Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2016. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-boxed-warning-and-new-recommendations-decrease-risk-hepatitis-b"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R118","doi-asserted-by":"publisher","first-page":"519","DOI":"10.7326\/0003-4819-148-7-200804010-00008","article-title":"Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy.","volume":"148","author":"Loomba","year":"2008","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R119","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1751-553X.2008.01092.x","article-title":"Sensitivity and specificity of anti-HBc screening assays\u2014which assay is best for blood donor screening?","volume":"31","author":"Hourfar","year":"2009","journal-title":"Int J Lab Hematol"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R120","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s11901-020-00522-0","article-title":"Hepatitis B core antibody: role in clinical practice in 2020.","volume":"19","author":"Gish","year":"2020","journal-title":"Curr Hepatol Rep"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R121","doi-asserted-by":"publisher","first-page":"794","DOI":"10.7326\/M17-1106","article-title":"Hepatitis B vaccination, screening, and linkage to care: best practice advice from the American College of Physicians and the Centers for Disease Control and Prevention.","volume":"167","author":"Abara","year":"2017","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R122","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/infdis\/jiab366","article-title":"Estimated prevalence and number of persons with isolated antibody to hepatitis B core antigen and associated occult hepatitis B, United States, 2001\u20132018.","volume":"225","author":"Spradling","year":"2022","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R123","unstructured":"Council of State and Territorial Epidemiologists. Public health reporting and national notification for acute hepatitis B infections. 11-ID-03. Atlanta, GA: Council of State and Territorial Epidemiologists; 2011. https:\/\/cdn.ymaws.com\/www.cste.org\/resource\/resmgr\/PS\/11-ID-03.pdf"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R124","unstructured":"Council of State and Territorial Epidemiologists. Public health reporting and national notification for chronic hepatitis B infections. 11-ID-04. Atlanta, GA: Council of State and Territorial Epidemiologists; 2011. https:\/\/cdn.ymaws.com\/www.cste.org\/resource\/resmgr\/PS\/11-ID-04.pdf"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R125","unstructured":"CDC. Viral hepatitis surveillance and case management: guidance for state, territorial, and local health departments. Atlanta, GA: CDC; 2021https:\/\/www.cdc.gov\/hepatitis\/statistics\/surveillanceguidance\/docs\/viral-hepatitis-surveillance-and-case-management_508.pdf"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R126","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1001\/jama.2020.22980","article-title":"Screening for hepatitis B virus infection in adolescents and adults: US Preventive Services Task Force recommendation statement.","volume":"324","author":"Krist","year":"2020","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7201a1-202303090715-R127","unstructured":"CDC. Planning and implementing screening and brief intervention for risky alcohol use: a step-by-step guide for primary care practices. Atlanta, GA: CDC, National Center on Birth Defects and Developmental Disabilities; 2014. https:\/\/www.cdc.gov\/ncbddd\/fasd\/documents\/AlcoholSBIImplementationGuide-P.pdf"}],"container-title":["MMWR. Recommendations and Reports"],"original-title":[],"deposited":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T07:21:41Z","timestamp":1678346501000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/72\/rr\/rr7201a1.htm?s_cid=rr7201a1_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,10]]},"references-count":127,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,3,10]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.rr7201a1","relation":{},"ISSN":["1057-5987","1545-8601"],"issn-type":[{"value":"1057-5987","type":"print"},{"value":"1545-8601","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3,10]]},"published":{"date-parts":[[2023,3,10]]}}}